首页> 外文期刊>Dental materials >Controlled release of metronidazole from composite poly-ε-caprolactone/alginate (PCL/alginate) rings for dental implants
【24h】

Controlled release of metronidazole from composite poly-ε-caprolactone/alginate (PCL/alginate) rings for dental implants

机译:甲硝唑从聚-ε-己内酯/藻酸盐(PCL /藻酸​​盐)复合环上的控释释放

获取原文
获取原文并翻译 | 示例
       

摘要

Objective. Dental implants provide support for dental crowns and bridges by serving as abutments for the replacement of missing teeth. To prevent bacterial accumulation and growth at the site of implantation, solutions such as systemic antibiotics and localized delivery of bactericidal agents are often employed. The objective of this study was to demonstrate a novel method of controlled localized delivery of antibacterial agents to an implant site using a biodegradable custom fabricated ring. Methods. The study involved incorporating a model antibacterial agent (metronidazole) into custom designed poly-ε-caprolactone/alginate (PCL/alginate) composite rings to produce the intended controlled release profile. The rings can be designed to fit around the body of any root form dental implants of various diameters, shapes and sizes. Results. In vitro release studies indicate that pure (100%) alginate rings exhibited an expected burst release of metronidazole in the first few hours, whereas Alginate/PCL composite rings produced a medium burst release followed by a sustained release for a period greater than 4 weeks. By varying the PCL/alginate weight ratios, we have shown that we can control the amount of antibacterial agents released to provide the minimal inhibitory concentration (MIC) needed for adequate protection. The fabricated composite rings have achieved a 50% antibacterial agent release profile over the first 48 h and the remaining amount slowly released over the remainder of the study period. The PCL/alginate agent release characteristic fits the Ritger-Peppas model indicating a diffusion-based mechanism during the 30-day study period. Significance. The developed system demonstrates a controllable drug release profile and the potential for the ring to inhibit bacterial biofilm growth for the prevention of diseases such as peri-implantitis resulting from bacterial infection at the implant site.
机译:目的。牙种植体可作为牙桥来替代缺失的牙齿,从而为牙冠和牙桥提供支撑。为了防止细菌在植入部位积聚和生长,通常使用诸如全身性抗生素和局部递送杀菌剂的溶液。这项研究的目的是演示一种使用可生物降解的定制环将抗菌剂控制局部递送至植入部位的新方法。方法。该研究涉及将模型抗菌剂(甲硝唑)掺入定制设计的聚-ε-己内酯/藻酸盐(PCL /藻酸​​盐)复合环中,以产生预期的控释曲线。这些环可以设计成适合各种直径,形状和大小的任何根形牙科植入物的身体。结果。体外释放研究表明,纯净的(100%)海藻酸盐环在最初的几个小时内显示出甲硝唑的预期爆发释放,而藻酸盐/ PCL复合环产生中等程度的爆发释放,然后持续释放超过4周。通过改变PCL /藻酸​​盐重量比,我们已经表明,我们可以控制抗菌剂的释放量,以提供充分保护所需的最小抑菌浓度(MIC)。制成的复合材料环在最初的48小时内已达到50%的抗菌剂释放曲线,而剩余量在研究期的剩余时间内缓慢释放。 PCL /藻酸​​盐剂释放特性符合Ritger-Peppas模型,表明在30天的研究期内基于扩散的机制。意义。研发的系统显示出可控的药物释放曲线,以及该环抑制细菌生物膜生长的潜力,可预防疾病,例如植入部位细菌感染导致的植入物周围炎。

著录项

  • 来源
    《Dental materials》 |2013年第6期|656-665|共10页
  • 作者单位

    Bioengineering Center, University of Oklahoma, Norman, OK 73019, USA;

    School of Chemical, Biological and Materials Engineering, University of Oklahoma, Norman, OK 73019, USA;

    Bioengineering Center, University of Oklahoma, Norman, OK 73019, USA;

    Bioengineering Center, University of Oklahoma, Norman, OK 73019, USA,College of Dentistry, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73117, USA;

    Bioengineering Center, University of Oklahoma, Norman, OK 73019, USA,School of Chemical, Biological and Materials Engineering, University of Oklahoma, Norman, OK 73019, USA;

    Bioengineering Center, University of Oklahoma, Norman, OK 73019, USA,School of Industrial & Systems Engineering, University of Oklahoma, Norman, OK 73019, USA;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Localized drug delivery; Dental implants; Poly-ε-caprolactone; Alginate; Solvent casting; Metronidazole;

    机译:局部药物输送;牙种植体;聚ε-己内酯;海藻酸盐;溶剂浇铸;甲硝唑;
  • 入库时间 2022-08-18 03:47:03

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号